CompletedNCT01941043
CERC-301 Added to Antidepressants for Severe Depression and Recent Suicidal Thoughts
About this title
Read the official source — NCT01941043Medication studyAges 18–70United States
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
- Listed locations
- Birmingham and 23 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNovember 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,357
- Sponsor
- Avalo Therapeutics, Inc.
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT01941043
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · Phoenix · Culver City
21 more locations
- Garden Grove
- Glendale
- National City
- Oakland
- Oceanside
- San Diego
- Jacksonville
- North Miami
- Orlando
- Atlanta
- Marietta
- Chicago
- Baltimore
- O'Fallon
- Mount Kisco
- New York
- Rochester
- Canton
- Media
- Dallas
- Bellevue
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Avalo Therapeutics, Inc.
Did this study involve medication?
Yes. The study involved medication, including CERC-301.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
